Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    22955125 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Cognitive Ability, General
Interventions: Drug: Ginkgo biloba;   Drug: Placebo
2 Not yet recruiting Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis
Conditions: Multiple Sclerosis, Relapsing-Remitting;   Multiple Sclerosis, Secondary Progressive;   Multiple Sclerosis, Primary Progressive
Interventions: Drug: Insulin;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.